RxDoctor Payments Data

Jay Lieberman, MD

Orthopaedic Surgery · Los Angeles, CANPI 1316959935

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $4,766,934 of the $4,803,558 with a category attached, or 99.2%. Depuy Synthes Products, Inc. accounts for 99.4% of it on its own, with 9 other manufacturers making up the rest. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,803,558in general payments, 2019–2025

Across 94 payments — averaging $51,102 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$4.8M
  • Regeneron$16K
  • Musculoskeletal Transplant Foundation Inc.$6K
  • Amgen$3K
  • Baxter Healthcare$1K
  • Pacira Pharmaceuticals Incorporated$955
  • plus $320 from 4 others
$1,256in research payments, 2019–2025

Across 2 payments — averaging $627.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$1K

What the payments were for

  • Royalty or licence$4,766,93499%
  • Consulting fees$27,3471%
  • Speaking & faculty fees$2,5000%
  • Travel & lodging$5,8950%
  • Food & beverage$8830%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,803,558 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$101,232
Medicare patients
347
Services billed
563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →